Cargando…

Nanomedicine Strategies to Target Tumor-Associated Macrophages

In recent years, the influence of the tumor microenvironment (TME) on cancer progression has been better understood. Macrophages, one of the most important cell types in the TME, exist in different subtypes, each of which has a different function. While classically activated M1 macrophages are invol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Binnemars-Postma, Karin, Storm, Gert, Prakash, Jai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454892/ https://www.ncbi.nlm.nih.gov/pubmed/28471401 http://dx.doi.org/10.3390/ijms18050979

Ejemplares similares

Cancer immune therapy using engineered ‛tail-flipping’ nanoliposomes targeting alternatively activated macrophages
por: Kuninty, Praneeth R., et al.
Publicado: (2022)

Nanomedicine strategies to target coronavirus
por: Heinrich, Marcel Alexander, et al.
Publicado: (2020)

Nanomedicine Strategies to Enhance Tumor Drug Penetration in Pancreatic Cancer
por: Lu, Tao, et al.
Publicado: (2021)

Nanomedicine Strategies for Targeting Tumor Stroma
por: Su, Mei-Chi, et al.
Publicado: (2023)

Macrophage Targeted Theranostics as Personalized Nanomedicine Strategies for Inflammatory Diseases
por: Patel, Sravan Kumar, et al.
Publicado: (2015)

Tumour-targeted nanomedicines: principles and practice
por: Lammers, T, et al.
Publicado: (2008)

Nanomedicine engulfed by macrophages for targeted tumor therapy
por: Li, Siwen, et al.
Publicado: (2016)

Nanomedicine formulations for combination therapies
por: Lammers, Twan, et al.
Publicado: (2010)

MicroRNA Targeting to Modulate Tumor Microenvironment
por: Kuninty, Praneeth R., et al.
Publicado: (2016)

Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis
por: Chen, Wei, et al.
Publicado: (2021)

Development of functional nanomedicines for tumor associated macrophages-focused cancer immunotherapy
por: Wei, Xiao, et al.
Publicado: (2022)

Macrophage-Targeted Nanomedicines for ARDS/ALI: Promise and Potential
por: Vichare, Riddhi, et al.
Publicado: (2022)

Targeting strategies for improving the efficacy of nanomedicine in oncology
por: Villaverde, Gonzalo, et al.
Publicado: (2019)

The interplay of the Notch signaling in hepatic stellate cells and macrophages determines the fate of liver fibrogenesis
por: Bansal, Ruchi, et al.
Publicado: (2015)

Targeting regulated cell death in tumor nanomedicines
por: Zeng, Qinghu, et al.
Publicado: (2022)

Macrophage-targeted nanomedicine for the diagnosis and management of atherosclerosis
por: Hu, Ping Ping, et al.
Publicado: (2022)

Nanomedicine Penetration to Tumor: Challenges, and Advanced Strategies to Tackle This Issue
por: Munir, Muhammad Usman
Publicado: (2022)

High-resolution 3D visualization of nanomedicine distribution in tumors
por: Moss, Jennifer I., et al.
Publicado: (2020)

Investigation into the Role of Tumor-Associated Macrophages in the Antitumor Activity of Doxil
por: Banciu, Manuela, et al.
Publicado: (2008)

Recent Trends in Nanomedicine-Based Strategies to Overcome Multidrug Resistance in Tumors
por: Khan, Muhammad Muzamil, et al.
Publicado: (2022)

Therapeutic Strategies to Overcome Fibrotic Barriers to Nanomedicine in the Pancreatic Tumor Microenvironment
por: Tanaka, Hiroyoshi Y., et al.
Publicado: (2023)

Cancer nanomedicine meets immunotherapy: opportunities and challenges
por: Sun, Qingxue, et al.
Publicado: (2020)

Nanomedicine for drug targeting: strategies beyond the enhanced permeability and retention effect
por: Nehoff, Hayley, et al.
Publicado: (2014)

Targeted Delivery of Nanomedicines
por: Kumar Khanna, Vinod
Publicado: (2012)

Role of macrophage in nanomedicine-based disease treatment
por: Song, Siwei, et al.
Publicado: (2021)

A Current Update on the Role of HDL-Based Nanomedicine in Targeting Macrophages in Cardiovascular Disease
por: Rani, Alankrita, et al.
Publicado: (2023)

Nanomedicines Targeting Metabolism in the Tumor Microenvironment
por: Ren, Mengdi, et al.
Publicado: (2022)

Recent advances in nanomedicines for regulation of macrophages in wound healing
por: Joorabloo, Alireza, et al.
Publicado: (2022)

Targeting tumor microenvironment: crossing tumor interstitial fluid by multifunctional nanomedicines
por: Omidi, Yadollah, et al.
Publicado: (2014)

Perspectives for Improving the Tumor Targeting of Nanomedicine via the EPR Effect in Clinical Tumors
por: Kim, Jinseong, et al.
Publicado: (2023)

Tumor extracellular matrix modulating strategies for enhanced antitumor therapy of nanomedicines
por: Li, Meng, et al.
Publicado: (2022)

Role of spleen tyrosine kinase in liver diseases
por: Kurniawan, Dhadhang Wahyu, et al.
Publicado: (2020)

Nanomedicine therapies modulating Macrophage Dysfunction: a potential strategy to attenuate Cytokine Storms in severe infections
por: Liu, Jingping, et al.
Publicado: (2020)

FGF2 engineered SPIONs attenuate tumor stroma and potentiate the effect of chemotherapy in 3D heterospheroidal model of pancreatic tumor
por: Mardhian, Deby Fajar, et al.
Publicado: (2020)

Drug Resistance in Metastatic Breast Cancer: Tumor Targeted Nanomedicine to the Rescue
por: Gote, Vrinda, et al.
Publicado: (2021)

Targeted nanomedicines remodeling immunosuppressive tumor microenvironment for enhanced cancer immunotherapy
por: Xu, Yanyan, et al.
Publicado: (2022)

Nanomedicine as a strategy to fight thrombotic diseases
por: Varna, Mariana, et al.
Publicado: (2015)

Strategies for Cancer Treatment Based on Photonic Nanomedicine
por: de Oliveira, Sueli Aparecida, et al.
Publicado: (2021)

Cancer Nanomedicine: Emerging Strategies and Therapeutic Potentials
por: Xu, Manman, et al.
Publicado: (2023)

Nanomedicine strategies to counteract cancer stemness and chemoresistance
por: Liu, Huayu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rbj146lmfdli45n09r72j2osk8